Parallel Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-582
Closed -$1.32K 3490
2023
Q1
$1.32K Sell
582
-122
-17% -$276 ﹤0.01% 2893
2022
Q4
$2.46K Buy
704
+700
+17,500% +$2.44K ﹤0.01% 2606
2022
Q3
$0 Buy
+4
New ﹤0.01% 3430
2021
Q4
Sell
-184
Closed -$5K 3266
2021
Q3
$5K Buy
+184
New +$5K ﹤0.01% 2361